Back to HomeBeta

ICD-10 Coding for Opioid-Induced Constipation(K59.03, T40.4X5A)

Complete ICD-10-CM coding and documentation guide for Opioid-Induced Constipation. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

OICDrug-induced constipation due to opioidsnarcoticinduced constipation

Related ICD-10 Code Ranges

Complete code families applicable to Opioid-Induced Constipation

K59-K59.9Primary Range

Functional intestinal disorders

Includes specific codes for drug-induced constipation, including opioid-induced constipation.

Poisoning by narcotics and psychodysleptics [hallucinogens]

Includes codes for adverse effects of synthetic narcotics, necessary for coding opioid-induced constipation.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
K59.03Drug-induced constipationUse when constipation is directly linked to opioid use.
  • Documentation of opioid use with temporal relationship to constipation onset
  • Bowel Function Index (BFI) score ≥28.8
  • Lack of response to laxatives
T40.4X5AAdverse effect of synthetic narcoticsUse alongside K59.03 to specify the narcotic causing the adverse effect.
  • Presence of opioid prescription
  • Temporal relationship to constipation

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for opioid-induced constipation

Essential facts and insights about Opioid-Induced Constipation

The ICD-10 code for opioid-induced constipation is K59.03, used with T40.4X5A for synthetic narcotics.

Primary ICD-10-CM Codes for opioid induced constipation

Drug-induced constipation
Billable Code

Decision Criteria

clinical Criteria

  • Constipation onset within 14 days of opioid initiation

documentation Criteria

  • BFI score ≥28.8 and lack of response to laxatives

Applicable To

  • Opioid-induced constipation

Excludes

Clinical Validation Requirements

  • Documentation of opioid use with temporal relationship to constipation onset
  • Bowel Function Index (BFI) score ≥28.8
  • Lack of response to laxatives

Code-Specific Risks

  • Incorrectly coding as general constipation (K59.00)

Coding Notes

  • Ensure documentation specifies the opioid and the temporal relationship to constipation.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Adverse effect of synthetic narcotics

T40.4X5A
Use to specify the narcotic causing the constipation.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Constipation, unspecified

K59.00
Use K59.03 when constipation is specifically linked to opioid use.

Drug-induced intestinal obstruction

K56.41
Use if imaging confirms obstruction rather than functional constipation.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Opioid-Induced Constipation to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code K59.03.

Impact

Clinical: May lead to inappropriate treatment, Regulatory: Non-compliance with coding standards, Financial: Potential claim denials

Mitigation Strategy

Always specify the opioid in documentation, Use BFI scores to support diagnosis

Impact

Reimbursement: Incorrect coding may lead to denied claims., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on opioid-related adverse effects.

Mitigation Strategy

Use T40.4X5A for synthetic narcotics.

Impact

Using general constipation codes instead of opioid-specific codes.

Mitigation Strategy

Educate staff on the importance of linking constipation to opioid use.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Opioid-Induced Constipation, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Opioid-Induced Constipation

Use these documentation templates to ensure complete and accurate documentation for Opioid-Induced Constipation. These templates include all required elements for proper coding and billing.

Pain Management Clinic Note

Specialty: Pain Management

Required Elements

  • History of opioid use
  • Bowel Function Index score
  • Response to laxatives
  • Specific opioid causing constipation

Example Documentation

62F with metastatic breast cancer on hydromorphone 8mg Q4H x 3 weeks. Developed Bristol Type 2 stools, <2 bowel movements/week (+5-day latency from opioid start). Failed senna 17.2mg BID x7 days. BFI: 34/100. Assessment: Opioid-induced constipation (K59.03) secondary to hydromorphone (T40.4X5A). Plan: Start naloxegol 25mg daily; monitor for response.

Examples: Poor vs. Good Documentation

Poor Documentation Example
Constipation, give Miralax.
Good Documentation Example
OIC confirmed per Rome IV criteria: New-onset straining + incomplete evacuation after oxycodone dose escalation. BFI: 29/100. Start methylnaltrexone SC weekly.
Explanation
The good example specifies the opioid link and includes clinical validation with BFI score.

Need help with ICD-10 coding for Opioid-Induced Constipation? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more